# Nunzia Pharmaceutical Company (NUNZ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NUNZ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 0 | $ -21.21M | $ -213.0K | $ 183.3K | $ -191.3K |
| 2021 | $ 0 | $ -92.79M | $ -103.1K | $ 0 | $ -94.2K |
| 2020 | $ 0 | $ -11.49M | $ -11.47M | $ 0 | $ -36.4K |
| 2019 | $ 0 | $ -43.4K | $ -4.9K | $ 0 | $ -22.6K |
| 2018 | $ 0 | $ -24.5K | $ 0 | $ 23.0K | $ -294.0K |
| 2009 | $ 0 | $ -98.4K | N/A | $ 1.95M | $ -3.88M |
| 2008 | N/A | N/A | N/A | $ 1.81M | $ -3.73M |
| 2007 | $ 0 | $ -224.1K | N/A | $ 1.67M | $ -3.59M |
| 2006 | $ 0 | $ -246.8K | N/A | $ 1.55M | $ -3.47M |
| 2005 | $ 0 | $ -493.6K | N/A | $ 1.43M | $ -3.35M |
| 2004 | $ 0 | $ -719.2K | N/A | $ 1.43M | $ -3.16M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.96 |
| Liabilities / Eq | -1.18 |
| Current Ratio | 0.16 |

## Other views

- [Metrics](https://sponda.capital/en/NUNZ.md)
- [Charts](https://sponda.capital/en/NUNZ/charts.md)
- [Compare](https://sponda.capital/en/NUNZ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.